Wain John, Diem Nga L T, Kidgell Claire, James Keith, Fortune Sarah, Song Diep To, Ali Tahir, O Gaora Peadar, Parry Christopher, Parkhill Julian, Farrar Jeremy, White Nicholas J, Dougan Gordon
Wellcome Trust Clinical Research Unit, Department of Biological Sciences, Imperial College, London.
Antimicrob Agents Chemother. 2003 Sep;47(9):2732-9. doi: 10.1128/AAC.47.9.2732-2739.2003.
The first outbreak of multidrug-resistant (MDR) typhoid fever in Vietnam was in 1993, and by 1995 nearly 90% of cases were MDR. Plasmid HCM1, sequenced in full, is an incHI1 plasmid from Salmonella enterica serovar Typhi strain CT18, isolated in Vietnam in 1993. Restriction analysis shows that pHCM1 shares a restriction fragment length polymorphism (RFLP) pattern with plasmids isolated from the first outbreak and 10 of 17 MDR plasmids isolated from sporadic cases occurring at the same time in Vietnam. A core region of pHCM1 has significant DNA sequence similarity to plasmid R27, isolated in 1961 from S. enterica in the United Kingdom. There are five regions of DNA in pHCM1 which are not present in R27. Two of these are putative acquisition regions; the largest is 34.955 kbp in length and includes sequences of several antibiotic resistance genes and several insertion sequences. The borders of this region are defined by two identical IS10 left elements, associated with an inversion of DNA or with a truncated Tn10 element. The second, smaller region is 14.751 kbp and carries a trimethoprim resistance gene dfr14A cassette associated with a class 1 integrase. In 1993 to 1994, restriction analysis revealed some variations in the structures of Salmonella serovar Typhi MDR plasmids which were mapped to the two putative acquisition regions and three smaller variable regions. In 1996 a single RFLP type, RFLP7, was found to carry the dfrA7 and sul-1 genes, which were not present on R27 or pHCM1. This plasmid type appears to have a selective advantage over other plasmids with the same resistance phenotype.
越南首次爆发多重耐药(MDR)伤寒热是在1993年,到1995年,近90%的病例为多重耐药。完全测序的质粒HCM1是一种来自肠炎沙门氏菌伤寒血清型CT18菌株的IncHI1质粒,于1993年在越南分离得到。限制性分析表明,pHCM1与从首次爆发中分离出的质粒以及从越南同期散发病例中分离出的17个多重耐药质粒中的10个具有限制性片段长度多态性(RFLP)模式。pHCM1的一个核心区域与1961年从英国肠炎沙门氏菌中分离出的质粒R27具有显著的DNA序列相似性。pHCM1中有五个DNA区域在R27中不存在。其中两个是假定的获得区域;最大的区域长度为34.955 kbp,包括几个抗生素抗性基因和几个插入序列的序列。该区域的边界由两个相同的IS10左元件界定,与DNA倒位或截短的Tn10元件相关。第二个较小的区域为14.751 kbp,携带与1类整合酶相关的甲氧苄啶抗性基因dfr14A盒。1993年至1994年,限制性分析揭示了伤寒沙门氏菌多重耐药质粒结构中的一些变异,这些变异被定位到两个假定的获得区域和三个较小的可变区域。1996年,发现一种单一的RFLP类型RFLP7携带dfrA7和sul-1基因,这些基因在R27或pHCM1上不存在。这种质粒类型似乎比具有相同抗性表型的其他质粒具有选择优势。